Tepotinib Treatment for MET Exon 14–Skipping NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial
JAMA Oncol 2023 Jun 04;[EPub Ahead of Print], J Mazieres, PK Paik, MC Garassino, X Le, H Sakai, R Veillon, EF Smit, AB Cortot, J Raskin, S Viteri, YL Wu, JCH Yang, MJ Ahn, R Ma, J Zhao, A O'Brate, K Berghoff, R Bruns, G Otto, A Johne, E Felip, M ThomasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.